Lauren M Sabella insider trades: Acorda Therapeutics (ACOR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lauren reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | ACOR | ↓ Sell10b5-1 | 1,513 | $1.60 | $2K | Direct | Dec 4, 2019 (2d) |
| Feb 22, 2019 | ACOR | ↓ Sell | 761 | $13.18 | $10K | Direct | Feb 25, 2019 (3d) |
| Dec 3, 2018 | ACOR | ↓ Sell10b5-1 | 5,191 | $20.56 | $107K | Direct | Dec 6, 2018 (3d) |
| Jun 28, 2018 | ACOR | ↓ Sell10b5-1 | 5,859 | $27.84 | $163K | Direct | Jul 2, 2018 (4d) |
| Jun 8, 2018 | ACOR | ↓ Sell10b5-1 | 24,375 | $35.00 | $853K | Direct | Jun 12, 2018 (4d) |
| May 18, 2018 | ACOR | ↓ Sell10b5-1 | 7,288 | $23.66 | $172K | Direct | May 22, 2018 (4d) |
| Dec 1, 2017 | ACOR | ↓ Sell10b5-1 | 1,670 | $20.53 | $34K | Direct | Dec 5, 2017 (4d) |
| Dec 1, 2016 | ACOR | ↓ Sell10b5-1 | 2,429 | $20.74 | $50K | Direct | Dec 5, 2016 (4d) |
| Dec 22, 2015 | ACOR | ↓ Sell10b5-1 | 7,113 | $42.04 | $299K | Direct | Dec 23, 2015 (1d) |
| Dec 17, 2015 | ACOR | ↓ Sell10b5-1 | 14,229 | $40.00 | $569K | Direct | Dec 21, 2015 (4d) |
| Dec 1, 2015 | ACOR | ↓ Sell10b5-1 | 7,106 | $38.06 | $270K | Direct | Dec 3, 2015 (2d) |
| Dec 1, 2014 | ACOR | ↓ Sell10b5-1 | 3,242 | $35.58 | $115K | Direct | Dec 3, 2014 (2d) |
| Dec 5, 2013 | ACOR | ↓ Sell10b5-1 | 8,797 | $31.81 | $280K | Direct | Dec 9, 2013 (4d) |
| Dec 2, 2013 | ACOR | ↓ Sell10b5-1 | 6,603 | $33.52 | $221K | Direct | Dec 4, 2013 (2d) |
| Nov 22, 2013 | ACOR | ↓ Sell10b5-1 | 10,949 | $33.72 | $369K | Direct | Nov 25, 2013 (3d) |
| Dec 4, 2012 | ACOR | ↓ Sell10b5-1 | 4,364 | $24.58 | $107K | Direct | Dec 5, 2012 (1d) |
| Dec 1, 2011 | ACOR | ↓ Sell10b5-1 | 4,364 | $22.91 | $100K | Direct | Dec 5, 2011 (4d) |
| Dec 1, 2010 | ACOR | ↓ Sell10b5-1 | 3,933 | $26.53 | $104K | Direct | Dec 3, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lauren M Sabella's insider trades
Lauren M Sabella is Chief Operating Officer at Acorda Therapeutics (ACOR). Since Dec 1, 2010, Lauren has reported no open-market purchases and 18 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
17 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (24 filings), shares withheld for taxes (8 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACOR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.